See other companies on Welcome to the Jungle

9amHealth

Provider of cardiometabolic healthcare

9amHealth logo
21-100 employees
  • Healthcare
  • B2C
  • B2B
  • Wellbeing
Encinitas, CA

Jump to section

Company mission

To deliver unlimited care from specialists across diabetes, obesity, and heart health to help our members live healthier every day.

Our take

The high cost of GLP-1 medications, used to treat diabetes and weight management, poses a challenge for both patients and employers. This expensive medication, while highly effective, creates a burden on healthcare systems and limits access for many who could benefit.

9amHealth steps in to address this issue by offering an affordable solution for cardiometabolic care. It provides patients with personalized care plans, medication delivery, at-home lab tests, and unlimited access to specialists. This not only simplifies the healthcare experience for patients but also boasts impressive clinical outcomes. Additionally, 9am partners with businesses to offer these benefits to their employees, helping manage healthcare costs and improve employee health.

Recently acquired capital will help the company fuel expansion, allowing it to reach more patients, improve its existing solutions, and strengthen its team of specialists. With a strong foundation and promising future, 9am is well-positioned to become a leader in affordable and effective cardiometabolic care.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • Health, vision, and dental plans
  • 20 vacation days (for full-time employees)
  • Flexible, hybrid working model

Leadership

Frank Westermann

(Co-CEO)

Alongside 9amHealth, they are the founder and CEO of Whitewater Ventures. Previously co-founded mySugr (acquired by Roche) and Zense-Life.

Anton Kittelberger

(Co-CEO)

Currently an Investor and Non-Executive Chairman at BOYDSense. Previously worked at mySugr for over 7 years in a number of roles, including CEO. They also worked at Roche and Detecon International.

Paul Geevarghese

(COO)

Previously held Vice President roles at Roche and mySugr. They were also a Senior Manager of Medical Affairs at Novo Nordisk.

Bernhard Schandl

(CTO)

Co-founder and Tech Advisor at inoqo. Previously the Head of Technology, CTO, and VP of Engineering at mySugr. They were also a Lecturer at Fachhochschule Technikum Wien for over 6 years.